M

Malin Corporation PLC
ISEQ:MLC

Watchlist Manager
Malin Corporation PLC
ISEQ:MLC
Watchlist
Price: 8.65 EUR -0.57% Market Closed
Market Cap: 162.7m EUR
Have any thoughts about
Malin Corporation PLC?
Write Note

Malin Corporation PLC
Investor Relations

Malin Corp. Plc.invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The company went IPO on 2015-03-25. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, CG Oncology, Wren, KNOW Bio and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates, initially focused on the treatment of hematological malignancies, including multiple myeloma, and solid tumours, like prostate cancer. The company is also developing two CAR-T therapies: autologous and allogeneic. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder-saving therapeutics for patients with bladder cancer.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. William F. Daniel
Executive Chairman of the Board
No Bio Available
Ms. Fiona Dunlevy
Company Secretary & Executive Director
No Bio Available
Andrea Stafford
Head of Finance
No Bio Available
Jessica Bergin
Director of Investor Relations & External Reporting
No Bio Available
Dr. Andrew C. von Eschenbach M.D.
Chief Medical Adviser
No Bio Available

Contacts

Address
DUBLIN
DUBLIN
The Lennox Building, 50 Richmond Street South
Contacts
+35319015700
malinplc.com